A phase I study of topotecan in combination with pemetrexed in patients with advanced malignancies.
Phase of Trial: Phase I
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Pemetrexed (Primary) ; Topotecan (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 22 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jan 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 02 Oct 2007 Status change from recruiting to in progress.